Expressions and significances of matrix metalloproteinase-9 and proliferating cell nuclear antigen in transitional cell carcinoma of bladder
Liu Ya
Abstract
Liu Ya
Abstract
Objective To evaluate the expressions and significances of matrix metalloproteinase-9 (MMP-9) and proliferating cell nuclear antigen (PCNA) in bladder transitional cell carcinoma (BTCC). Method The expressions of MMP-9 and PCNA in 58 cases of BTCC and 10 cases of normal bladder tissues were detected by SP immunohistochemical technique. Results The expression rates of MMP-9 and PCNA were higher in BTCC than those in normal bladder tissues (65.5% and 69.0% vs 0 and 10.0%,P0.01), and were higher in high grade BTCC than those in low grade BTCC (78.0% and 85.4% vs 35.3% and 29.4%,P0.01), and were higher in invasive BTCC than those in superficial BTCC (83.3% and 86.1% vs 36.4% and 40.9%, P0.01). There were positive correlation between the expressions of MMP-9 and PCNA in BTCC (r=0.451,P0.01). Conclusion MMP-9 and PCNA may play an important role in the development of BTCC, and combined detection of them may be benefit to evaluating the malignancy and predicting the prognosis of BTCC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the expressions and significances of matrix metalloproteinase-9 (MMP-9) and proliferating cell nuclear antigen (PCNA) in bladder transitional cell carcinoma (BTCC). Method The expressions of MMP-9 and PCNA in 58 cases of BTCC and 10 cases of normal bladder tissues were detected by SP immunohistochemical technique. Results The expression rates of MMP-9 and PCNA were higher in BTCC than those in normal bladder tissues (65.5% and 69.0% vs 0 and 10.0%,P0.01), and were higher in high grade BTCC than those in low grade BTCC (78.0% and 85.4% vs 35.3% and 29.4%,P0.01), and were higher in invasive BTCC than those in superficial BTCC (83.3% and 86.1% vs 36.4% and 40.9%, P0.01). There were positive correlation between the expressions of MMP-9 and PCNA in BTCC (r=0.451,P0.01). Conclusion MMP-9 and PCNA may play an important role in the development of BTCC, and combined detection of them may be benefit to evaluating the malignancy and predicting the prognosis of BTCC.
Key concepts: Proliferating cell nuclear antigen, Immunohistochemistry, Transitional cell carcinoma, Matrix metalloproteinase, Malignancy, Medicine, Nuclear matrix, Antigen